Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

ICU Medical, Inc. develops, manufactures, and sells disposable medical connection systems for use in intravenous (IV) therapy applications. The Company"s products are designed to prevent accidental disconnection of IV lines and to protect healthcare workers and their patients from the spread of infectious disease such as Hepatitis B and Human Immunodeficiency Virus (HIV).
Website: icumed.com


  • Bad financial results growth rate -3.6% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (29.7%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 6.2% (LTM)
  • Share price is 88.5% higher than minimum and 26.9% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (17.2x vs 23.4x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $0.4 mln (-0.012% of cap.)

Key Financials (Download financials)

Ticker: ICUI
Share price, USD:  (0.0%)152.86
year average price 136.36  


year start price 158.33 2025-02-13

max close price 164.13 2025-02-19

min close price 108.10 2025-08-11

current price 152.86 2026-02-12
Common stocks: 24 686 000

Dividend Yield:  0.0%
FCF Yield LTM: 6.2%
EV / LTM EBITDA: 17.2x
EV / EBITDA annualized: 18.4x
Last revenue growth (y/y):  -8.8%
Last growth of EBITDA (y/y):  +1.6%
Historical revenue growth:  +6.5%
Historical growth of EBITDA:  +52.9%
EV / Sales: 2.1x
Margin (EBITDA LTM / Revenue): 12.0%

Target EV / EBITDA (hist percentile): 23.4x
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 3 774
Net Debt ($m): 1 014
EV (Enterprise Value): 4 788
EBITDA LTM (млн $): 278
EV / LTM EBITDA: 17.2x
Price to Book: 1.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-14seekingalpha.com

ICU Medical, Inc. (ICUI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-11-06seekingalpha.com

ICU Medical, Inc. (ICUI) Q3 2025 Earnings Call Transcript

2025-08-10seekingalpha.com

ICU Medical, Inc. (ICUI) Q2 2025 Earnings Call Transcript

2025-05-10seekingalpha.com

ICU Medical, Inc. (ICUI) Q1 2025 Earnings Call Transcript

2025-05-08zacks.com

ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates

2025-04-29accessnewswire.com

ICU Medical, Inc. (ICUI) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

2025-04-24businesswire.com

ICUI Investors Have Opportunity to Join ICU Medical, Inc. Fraud Investigation with the Schall Law Firm

2025-04-09zacks.com

ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts

2025-02-27seekingalpha.com

ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call Transcript

2024-11-12seekingalpha.com

ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984
fillingDate 2025-11-06 2025-08-07 2024-11-12 2024-08-07 2024-05-07 2023-11-06 2023-08-07 2023-05-09 2022-11-07
acceptedDate 2025-11-06 16:39:26 2025-08-07 16:17:58 2025-02-27 17:24:45 2024-11-12 17:01:30 2024-08-07 17:07:01 2024-05-07 16:29:39 2024-02-27 17:05:29 2023-11-06 16:57:29 2023-08-07 17:22:02 2023-05-08 17:34:32 2023-02-27 17:31:30 2022-11-07 17:27:26 2022-02-25 16:53:47 2021-02-26 16:59:32
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 537M 549M 2 382M 589M 596M 566M 2 259M 553M 549M 569M 2 280M 598M 1 316M 1 271M
costOfRevenue 336M 341M 1 557M 384M 389M 383M 1 519M 369M 357M 377M 1 582M 411M 825M 810M
grossProfit 201M 208M 825M 205M 207M 183M 740M 184M 192M 192M 698M 186M 491M 461M
grossProfitRatio 0.374 0.379 0.348 0.348 0.324 0.332 0.35 0.338 0.312
researchAndDevelopmentExpenses 21M 22M 89M 21M 23M 22M 85M 21M 22M 20M 93M 23M 47M 43M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 153M 159M 639M 163M 160M 158M 607M 149M 151M 153M 608M 153M 303M 284M
otherExpenses 13M 16M 54M 13M 17M -682 000 25M -4M -2M -269 000 39M 0 18M 36M
operatingExpenses 187M 197M 782M 197M 200M 179M 717M 169M 173M 172M 741M 177M 368M 363M
costAndExpenses 523M 538M 2 339M 581M 589M 562M 2 236M 539M 530M 549M 2 323M 588M 1 193M 1 173M
interestIncome 0 3M 11M 3M 3M 3M 8M 2M 2M 0 4M 0 3M 4M
interestExpense 20M 23M 107M 27M 27M 26M 103M 24M 24M 23M 71M 21M 858 000 2M
depreciationAndAmortization 51M 50M 2M 56M 55M 56M 229M 58M 58M 56M 235M 59M 99M 95M
ebitda 67M 106M 43M 65M 80M 59M 253M 69M 75M 75M 192M 69M 223M 194M
ebitdaratio 0.124 0.194 0.11 0.134 0.105 0.124 0.137 0.132 0.115
operatingIncome 14M 11M 43M 8M 8M 4M 23M 23M 3M 19M -43M 10M 123M 98M
operatingIncomeRatio 0.026 0.019 0.014 0.013 0.007 0.041 0.005 0.034 0.017
totalOtherIncomeExpensesNet -18M 26M -109M -26M -27M -41M -101M 4M -18M -33M -72M -31M -59 000 -668 000
incomeBeforeTax -4M 37M -66M -18M -20M -37M -78M -5M -23M -13M -114M -21M 123M 97M
incomeBeforeTaxRatio -0.008 0.067 -0.03 -0.033 -0.065 -0.01 -0.042 -0.024 -0.036
incomeTaxExpense -658 000 1M 52M 15M 2M 3M -49M -13M -13M -4M -40M -8M 20M 11M
netIncome -3M 35M -118M -33M -21M -39M -30M 7M -10M -10M -74M -13M 103M 87M
netIncomeRatio -0.006 0.064 -0.056 -0.036 -0.07 0.013 -0.018 -0.017 -0.022
eps -0.14 1.43 -4.83 -1.35 -0.88 -1.63 -1.23 0.3 -0.41 -0.41 -3.11 -0.55 4.86 4.16
epsdiluted -0.14 1.43 -1.35 -0.88 -1.63 0.3 -0.41 -0.41 -0.55
weightedAverageShsOut 25M 25M 24M 24M 24M 24M 24M 24M 24M 24M 24M 24M 21M 21M
weightedAverageShsOutDil 25M 25M 24M 24M 24M 24M 24M 24M 24M 24M 24M 24M 22M 22M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-02-27 2022-02-25 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -96M -95M -66M 2M 2M
ebit 41M 24M -44M 124M 99M
nonOperatingIncomeExcludingInterest 2M -2M 706 000 -921 000 -1M
netIncomeFromContinuingOperations -118M -30M -74M 103M 87M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -118M -30M -74M 103M 87M
epsDiluted -4.83 -1.23 -3.11 4.74 4.02

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984
fillingDate 2025-11-06 2025-08-07 2024-11-12 2024-08-07 2024-05-07 2023-11-06 2023-08-07 2023-05-09 2022-11-07
acceptedDate 2025-11-06 16:39:26 2025-08-07 16:17:58 2025-02-27 17:24:45 2024-11-12 17:01:30 2024-08-07 17:07:01 2024-05-07 16:29:39 2024-02-27 17:05:29 2023-11-06 16:57:29 2023-08-07 17:22:02 2023-05-08 17:34:32 2023-02-27 17:31:30 2022-11-07 17:27:26 2022-02-25 16:53:47 2021-02-26 16:59:32
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 300M 300M 309M 313M 303M 251M 254M 197M 196M 221M 209M 244M 553M 396M
shortTermInvestments 0 0 0 0 303M 1M 501 000 2M 2M 3M 4M 3M 14M 15M
cashAndShortTermInvestments 300M 300M 309M 313M 303M 251M 255M 199M 198M 224M 213M 247M 567M 411M
netReceivables 217M 219M 203M 199M 155M 169M 182M 162M 162M 139M 247M 218M 125M 128M
inventory 622M 616M 585M 692M 683M 693M 709M 760M 775M 748M 696M 625M 290M 315M
otherCurrentAssets 68M 44M 321M 55M 69M 5M 41M 84M 96M 87M 43M 3M 20M 25M
totalCurrentAssets 1 207M 1 180M 1 442M 1 258M 1 236M 1 188M 1 221M 1 219M 1 245M 1 213M 1 235M 1 199M 1 030M 914M
propertyPlantEquipmentNet 513M 511M 499M 655M 664M 670M 686M 683M 693M 704M 714M 735M 511M 513M
goodwill 1 499M 1 502M 1 433M 1 478M 1 451M 1 459M 1 472M 1 444M 1 464M 1 463M 1 449M 1 370M 43M 33M
intangibleAssets 665M 698M 741M 786M 806M 837M 871M 891M 930M 958M 983M 1 021M 188M 197M
goodwillAndIntangibleAssets 2 164M 2 200M 2 174M 2 264M 2 257M 2 296M 2 343M 2 336M 2 394M 2 420M 2 432M 2 390M 232M 230M
longTermInvestments 134M 132M 9M 0 38M 3M 3M 3M 3M 0 4M 5M 8M 13M
taxAssets 24M 23M 24M 41M 39M 40M 37M 31M 31M 31M 31M 15M 43M 31M
otherNonCurrentAssets 61M 61M 56M 87M 53M 91M 88M 105M 97M 102M 100M 105M 58M 62M
totalNonCurrentAssets 2 896M 2 927M 2 762M 3 047M 3 051M 3 101M 3 157M 3 157M 3 218M 3 258M 3 280M 3 251M 851M 849M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 4 103M 4 107M 4 204M 4 305M 4 287M 4 288M 4 378M 4 377M 4 463M 4 471M 4 516M 4 450M 1 881M 1 764M
accountPayables 172M 169M 148M 169M 156M 152M 150M 149M 167M 186M 216M 205M 81M 72M
shortTermDebt 0 0 51M 51M 70M 70M 51M 46M 40M 35M 30M 43M 0 9M
taxPayables 5M 159 000 11M 6M 4M 11M 17M 11M 20M 6M 18M 26M 8M 2M
deferredRevenue 29M 22M 30M 0 34M 33M 32M 29M 28M 31M 31M 31M 13M 6M
otherCurrentLiabilities 287M 292M 103M 324M 249M 201M 71M 240M 249M 210M 43M 210M 33M 54M
totalCurrentLiabilities 493M 483M 556M 550M 512M 455M 482M 464M 484M 462M 495M 489M 201M 195M
longTermDebt 1 365M 1 390M 1 532M 1 543M 1 609M 1 618M 1 578M 1 589M 1 601M 1 612M 1 624M 1 694M 0 0
deferredRevenueNonCurrent 0 0 9M 0 10M 11M 11M 12M 15M 0 16M 22M 0 1M
deferredTaxLiabilitiesNonCurrent 41M 43M 49M 49M 54M 56M 56M 78M 90M 115M 126M 154M 1M 2M
otherNonCurrentLiabilities 77M 75M 50M 115M 64M 81M 74M 136M 159M 181M 102M 1 669M 26M 20M
totalNonCurrentLiabilities 1 483M 1 509M 1 683M 1 707M 1 737M 1 765M 1 773M 1 814M 1 864M 1 908M 1 931M 1 949M 64M 66M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 51M 52M 59M 0 73M 70M 75M 79M 81M 20M 81M 83M 45M 43M
totalLiabilities 1 976M 1 992M 2 239M 2 256M 2 249M 2 221M 2 255M 2 279M 2 348M 2 370M 2 426M 2 438M 265M 261M
preferredStock 0 0 0 0 0 1 0 0 0 0 0 0 0 0
commonStock 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
retainedEarnings 707M 710M 690M 714M 747M 768M 808M 825M 818M 828M 838M 853M 912M 809M
accumulatedOtherComprehensiveIncomeLoss -33M -33M -139M -62M -92M -70M -53M -85M -49M -62M -81M -166M -19M -2M
othertotalStockholdersEquity 1 451M 1 436M 1 395M 1 380M 1 367M 1 356M 1 343M 1 332M 1 323M
totalStockholdersEquity 2 127M 2 116M 1 965M 2 049M 2 038M 2 068M 2 123M 2 098M 2 115M 2 100M 2 090M 2 013M 1 616M 1 502M
totalEquity 2 127M 2 116M 1 965M 2 049M 2 038M 2 068M 2 123M 2 098M 2 115M 2 100M 2 090M 2 013M 1 616M 1 502M
totalLiabilitiesAndStockholdersEquity 4 103M 4 107M 4 305M 4 287M 4 288M 4 377M 4 463M 4 471M 4 450M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 4 103M 4 107M 4 204M 4 305M 4 287M 4 288M 4 378M 4 377M 4 463M 4 471M 4 516M 4 450M 1 881M 1 764M
totalInvestments 134M 132M 9M 3M 38M 15M 4M 2M 2M 3M 8M 8M 22M 28M
totalDebt 1 365M 1 390M 1 642M 1 594M 1 679M 1 687M 1 704M 1 635M 1 641M 1 647M 1 734M 1 737M 45M 53M
netDebt 1 065M 1 090M 1 333M 1 282M 1 377M 1 436M 1 450M 1 438M 1 445M 1 426M 1 526M 1 494M -508M -343M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-02-27 2022-02-25 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 183M 162M 222M 106M 124M
otherReceivables 20M 21M 25M 19M 4M
prepaids 25M 34M 36M 27M 36M
totalPayables 174M 168M 234M 89M 74M
otherPayables 26M 17M 18M 8M 2M
accruedExpenses 182M 140M 139M 57M 53M
capitalLeaseObligationsCurrent 16M 20M 18M 9M 0
capitalLeaseObligationsNonCurrent 43M 55M 63M 36M 43M
treasuryStock -92 000 -262 000 -243 000 -27 000 -39 000
additionalPaidInCapital 1 412M 1 366M 1 331M 721M 693M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI ICUI
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984 883 984
fillingDate 2025-11-06 2025-08-07 2024-11-12 2024-08-07 2024-05-07 2023-11-06 2023-08-07 2023-05-09 2022-11-07
acceptedDate 2025-11-06 16:39:26 2025-08-07 16:17:58 2025-02-27 17:24:45 2024-11-12 17:01:30 2024-08-07 17:07:01 2024-05-07 16:29:39 2024-02-27 17:05:29 2023-11-06 16:57:29 2023-08-07 17:22:02 2023-05-08 17:34:32 2023-02-27 17:31:30 2022-11-07 17:27:26 2022-02-25 16:53:47 2021-02-26 16:59:32
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -3M 35M -118M -33M -21M -39M -30M 7M -10M -10M -74M -13M 103M 87M
depreciationAndAmortization 52M 50M 241M 56M 55M 56M 229M 58M 58M 56M 235M 59M 90M 95M
deferredIncomeTax 0 0 0 0 0 0 0 -13M 4M 0 0 0 0 4M
stockBasedCompensation 15M 14M 47M 12M 11M 12M 41M 11M 10M 9M 36M 9M 27M 24M
changeInWorkingCapital -26M -49M -3M -13M 24M 4M -136M -38M -82M -30M -304M -63M 15M -17M
accountsReceivables -13M -6M -47M -18M 0 14M 49M -4M -35M 82M -19M -8M 14M 78M
inventory -7M -21M 17M -12M 7M 14M -6M 9M -27M -49M -201M -52M 21M 19M
accountsPayables 0 -18M 13M 12M 4M 5M -68M -18M -19M -28M 37M 8M 2M -46M
otherWorkingCapital -6M -5M 15M 5M 13M -29M -110M -25M -873 000 -35M -121M -12M -22M -68M
otherNonCashItems 18M -39M 37M 15M 13M 103M 62M 9M 20M 16M 45M 11M 32M 30M
netCashProvidedByOperatingActivities 57M 11M 204M 36M 82M 46M 166M 35M -1M 41M -62M 2M 268M 223M
investmentsInPropertyPlantAndEquipment -29M -20M -79M -15M -22M -19M -84M -25M -20M -17M -90M -23M -69M -100M
acquisitionsNet 0 0 0 -692 000 0 507 000 0 50 000 1M 0 -1 844M 0 -14M -8M
purchasesOfInvestments 0 0 0 0 0 0 0 0 -1M 0 -3M 0 -13M -33M
salesMaturitiesOfInvestments 0 0 500 000 0 0 500 000 4M 0 1M 2M 36M 10M 18M 29M
otherInvestingActivites -948 000 207M -8M 185 000 507 000 50 000 1M 54 000 33 000
netCashUsedForInvestingActivites -30M 187M -23M -22M -18M -25M -18M -15M -13M
debtRepayment -26M -201M -10M -13M -13M -8M -8M -8M -2M
commonStockIssued 0 6M -3M 0 150 000 2M 2M 171 000 0
commonStockRepurchased -31 000 0 -12M 12M 0 -11M -9M -503 000 -293 000 0 0 0 0 -13M
dividendsPaid 0 0 0 0 0 0 -2M 0 0
otherFinancingActivites 0 -297 000 27 000 3M -14M 1M 2M -8M 5M
netCashUsedProvidedByFinancingActivities -26M -195M -10M -10M -27M -6M -6M -16M 3M
effectOfForexChangesOnCash -1M 7M -5M 7M 1M -4M 3M -3M -83 000 2M -9M -4M -3M 3M
netChangeInCash -293 000 10M 54M 10M 51M -3M 45M 1M -25M 12M -344M -12M 157M 127M
cashAtEndOfPeriod 300M 300M 309M 313M 303M 251M 254M 197M 196M 221M 209M 244M 553M 396M
cashAtBeginningOfPeriod 300M 290M 254M 303M 251M 254M 209M 196M 221M 209M 553M 256M 396M 269M
operatingCashFlow 57M 11M 204M 36M 82M 46M 166M 35M -1M 41M -62M 2M 268M 223M
capitalExpenditure -29M -22M -79M -15M -22M -19M -94M -25M -20M -17M -99M -23M -81M -100M
freeCashFlow 28M -11M 125M 22M 60M 27M 73M 11M -22M 25M -161M -20M 186M 122M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-02-27 2022-02-25 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -10M -8M -8M -12M 15M
netCashProvidedByInvestingActivities -89M -88M -1 909M -91M -98M
netDebtIssuance -52M -31M 1 641M -607 000 -357 000
longTermNetDebtIssuance -52M -31M 1 641M -607 000 -357 000
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -1M -5M 0 0 317 000
netCommonStockIssuance -1M -5M 0 0 317 000
commonStockIssuance 11M 4M 0 0 13M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -3M 0 -4M -16M 0
netCashProvidedByFinancingActivities -56M -36M 1 637M -17M -40 000
incomeTaxesPaid 25M 36M 28M 20M 32M
interestPaid 100M 96M 64M 858 000 2M

Earning call transcript

2025 q3
2025-11-06 ET (fiscal 2025 q3)
2025 q2
2025-08-10 ET (fiscal 2025 q2)
2025 q1
2025-05-08 ET (fiscal 2025 q1)
2024 q4
2025-02-27 ET (fiscal 2024 q4)
2024 q3
2024-11-12 ET (fiscal 2024 q3)
2024 q2
2024-08-07 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-02-27 ET (fiscal 2023 q4)
2023 q3
2023-11-06 ET (fiscal 2023 q3)
2023 q2
2023-08-07 ET (fiscal 2023 q2)
2023 q1
2023-05-09 ET (fiscal 2023 q1)
2022 q4
2023-02-27 ET (fiscal 2022 q4)
2022 q3
2022-11-08 ET (fiscal 2022 q3)
2022 q2
2022-08-08 ET (fiscal 2022 q2)
2022 q1
2022-05-09 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-06 16:39 ET
ICU Medical reported for 2025 q3
SEC form 8
2025-11-06 16:10 ET
ICU Medical published news for 2025 q3
SEC form 8
2025-11-06 16:10 ET
ICU Medical published news for 2025 q3
SEC form 10
2025-08-07 20:17 ET
ICU Medical reported for 2025 q2
SEC form 8
2025-08-07 20:11 ET
ICU Medical published news for 2025 q2
SEC form 8
2025-08-07 20:11 ET
ICU Medical published news for 2025 q2
SEC form 10
2025-05-08 21:06 ET
ICU Medical reported for 2025 q1
SEC form 8
2025-05-08 20:08 ET
ICU Medical published news for 2025 q1
SEC form 8
2025-05-08 20:08 ET
ICU Medical published news for 2025 q1
SEC form 10
2025-05-08 00:00 ET
ICU Medical published news for 2025 q1
SEC form 10
2025-02-27 17:24 ET
ICU Medical reported for 2024 q4
SEC form 8
2025-02-27 16:10 ET
ICU Medical published news for 2024 q4
SEC form 8
2025-02-27 16:10 ET
ICU Medical published news for 2024 q4
SEC form 10
2025-02-27 00:00 ET
ICU Medical published news for 2024 q4
SEC form 10
2024-11-12 17:01 ET
ICU Medical reported for 2024 q3
SEC form 8
2024-11-12 16:08 ET
ICU Medical published news for 2024 q3
SEC form 8
2024-11-12 16:08 ET
ICU Medical published news for 2024 q3
SEC form 10
2024-11-12 00:00 ET
ICU Medical published news for 2024 q3
SEC form 10
2024-08-07 17:07 ET
ICU Medical reported for 2024 q2
SEC form 8
2024-08-07 16:19 ET
ICU Medical published news for 2024 q2
SEC form 8
2024-08-07 16:19 ET
ICU Medical published news for 2024 q2
SEC form 10
2024-08-07 00:00 ET
ICU Medical published news for 2024 q2
SEC form 10
2024-05-07 16:29 ET
ICU Medical published news for 2024 q1
SEC form 8
2024-05-07 16:07 ET
ICU Medical published news for 2024 q1
SEC form 8
2024-05-07 16:07 ET
ICU Medical reported for 2024 q1
SEC form 10
2024-05-07 00:00 ET
ICU Medical published news for 2024 q1
SEC form 10
2024-02-27 17:05 ET
ICU Medical published news for 2023 q4
SEC form 8
2024-02-27 16:11 ET
ICU Medical published news for 2023 q4
SEC form 8
2024-02-27 16:11 ET
ICU Medical reported for 2023 q4
SEC form 10
2024-02-27 00:00 ET
ICU Medical published news for 2023 q4
SEC form 10
2023-11-06 16:57 ET
ICU Medical published news for 2023 q3
SEC form 8
2023-11-06 16:09 ET
ICU Medical reported for 2023 q3
SEC form 10
2023-11-06 00:00 ET
ICU Medical published news for 2023 q3
SEC form 10
2023-08-07 17:22 ET
ICU Medical published news for 2023 q2
SEC form 6
2023-08-07 16:08 ET
ICU Medical reported for 2023 q2
SEC form 8
2023-08-07 00:00 ET
ICU Medical published news for 2023 q2
SEC form 10
2023-08-07 00:00 ET
ICU Medical published news for 2023 q2
SEC form 10
2023-05-09 00:00 ET
ICU Medical published news for 2023 q1
SEC form 8
2023-05-08 00:00 ET
ICU Medical reported for 2023 q1
SEC form 10
2023-02-27 17:31 ET
ICU Medical reported for 2022 q4
SEC form 6
2023-02-27 16:10 ET
ICU Medical published news for 2022 q4
SEC form 8
2023-02-27 00:00 ET
ICU Medical reported for 2022 q4
SEC form 10
2023-02-27 00:00 ET
ICU Medical reported for 2022 q4
SEC form 6
2023-01-03 16:02 ET
ICU Medical published news for 2022 q4
SEC form 10
2022-11-07 17:27 ET
ICU Medical reported for 2022 q3
SEC form 6
2022-11-07 16:11 ET
ICU Medical published news for 2022 q3
SEC form 10
2022-11-07 00:00 ET
ICU Medical reported for 2022 q3
SEC form 8
2022-11-07 00:00 ET
ICU Medical reported for 2022 q3
SEC form 10
2022-08-09 00:00 ET
ICU Medical reported for 2022 q2
SEC form 10
2022-08-08 19:34 ET
ICU Medical reported for 2022 q2
SEC form 6
2022-08-08 16:18 ET
ICU Medical published news for 2022 q2
SEC form 8
2022-08-08 00:00 ET
ICU Medical reported for 2022 q2
SEC form 6
2022-05-18 10:21 ET
ICU Medical published news for 2022 q1
SEC form 10
2022-05-09 17:15 ET
ICU Medical reported for 2022 q1
SEC form 6
2022-05-09 16:13 ET
ICU Medical published news for 2022 q1
SEC form 8
2022-05-09 00:00 ET
ICU Medical reported for 2022 q1
SEC form 10
2022-05-09 00:00 ET
ICU Medical reported for 2022 q1
SEC form 6
2022-04-20 17:24 ET
ICU Medical published news for 2022 q1
SEC form 6
2022-04-04 16:40 ET
ICU Medical published news for 2022 q1
SEC form 6
2022-03-21 16:09 ET
ICU Medical published news for 2021 q4
SEC form 10
2022-02-25 16:53 ET
ICU Medical published news for 2021 q4
SEC form 10
2022-02-25 00:00 ET
ICU Medical published news for 2021 q4
SEC form 6
2022-02-24 16:11 ET
ICU Medical published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
ICU Medical published news for 2021 q4
SEC form 6
2022-02-18 08:57 ET
ICU Medical published news for 2021 q4
SEC form 6
2022-02-03 13:56 ET
ICU Medical published news for 2021 q4
SEC form 6
2022-02-01 09:00 ET
ICU Medical published news for 2021 q4
SEC form 6
2022-01-10 16:38 ET
ICU Medical published news for 2021 q4
SEC form 6
2022-01-07 08:59 ET
ICU Medical published news for 2021 q4
SEC form 6
2022-01-04 16:39 ET
ICU Medical published news for 2021 q4
SEC form 6
2022-01-04 16:32 ET
ICU Medical published news for 2021 q4
SEC form 10
2021-11-05 17:01 ET
ICU Medical published news for 2021 q3
SEC form 10
2021-11-05 00:00 ET
ICU Medical published news for 2021 q3
SEC form 6
2021-11-03 16:10 ET
ICU Medical published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
ICU Medical published news for 2021 q3
SEC form 6
2021-09-28 17:03 ET
ICU Medical published news for 2021 q2
SEC form 6
2021-09-08 09:08 ET
ICU Medical published news for 2021 q2
SEC form 6
2021-08-09 08:14 ET
ICU Medical published news for 2021 q2
SEC form 10
2021-08-04 16:33 ET
ICU Medical published news for 2021 q2
SEC form 6
2021-08-04 16:13 ET
ICU Medical published news for 2021 q2
SEC form 10
2021-08-04 00:00 ET
ICU Medical published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
ICU Medical published news for 2021 q2
SEC form 6
2021-07-07 16:14 ET
ICU Medical published news for 2021 q2
SEC form 6
2021-05-14 13:29 ET
ICU Medical published news for 2021 q1
SEC form 10
2021-05-07 13:42 ET
ICU Medical published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
ICU Medical published news for 2021 q1
SEC form 6
2021-05-06 16:12 ET
ICU Medical published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
ICU Medical published news for 2021 q1
SEC form 6
2021-04-01 14:44 ET
ICU Medical published news for 2021 q1
SEC form 10
2021-02-26 16:59 ET
ICU Medical published news for 2020 q4
SEC form 6
2021-02-25 16:10 ET
ICU Medical published news for 2020 q4
SEC form 10
2020-11-06 15:27 ET
ICU Medical published news for 2020 q3
SEC form 6
2020-11-05 16:14 ET
ICU Medical published news for 2020 q3